ECDC study protocol for genomic-based surveillance of carbapenem-resistant and/or colistin-resistant Enterobacteriaceae at the EU level
This ECDC study protocol describes the technical requirements for implementing future EU-level genomic-based surveillance of carbapenem-resistant and/or colistin-resistant Enterobacteriaceae. It is meant to guide the consolidation of ECDC activities in relation to the molecular typing of multidrug-resistant pathogens and focus on the development of genomic typing-enhanced surveillance. It builds upon and synthesises evidence and the opinion of experts in Member States and at ECDC compiled since 2014.
The protocol was updated in July 2018 with minor changes to certain definitions and incorporates feedback received during a consultation with national technical coordinators at the inaugural meeting for the survey in November 2017.
Laboratory manual for carbapenem and colistin resistance detection and characterisation for the survey of carbapenem- and/or colistin-resistant Enterobacteriaceae
18 Feb 2019 - This protocol is based partly on the laboratory manual developed for the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE)
ECDC country visit to Norway to discuss antimicrobial resistance issues
16 Jan 2019 - An ECDC country visit team conducted an assessment mission during the period 12–16 March 2018 to discuss antimicrobial resistance (AMR) issues in Norway. The overall objective of the mission was to provide an observation-based assessment of the situation in Norway regarding prevention and control of AMR through prudent use of antibiotics and infection control.
Communicable disease threats report, 8-14 July 2018, week 28
13 Jul 2018 - This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 8-14 July 2018 and includes updates on carbapenemase-producing (OXA-48) Klebsiella pneumoniae, dengue, Ebola virus disease, poliomyelitis, MERS-CoV, mass gathering monitoring (FIFA Men's Football World Cup), measles, poliovirus type 2, rubella, Vibrio growth in the Baltic Sea, and West Nile virus.